Understanding the Unique Impact of Chronic Myeloid Leukemia on Black Women

Chronic Myeloid Leukemia (CML) disproportionately impacts Black women, influenced by hormonal, genetic, and healthcare disparities. Limited research on treatment responses and genetic variations exacerbates these challenges. Increasing awareness, enhancing healthcare access, and promoting clinical trial participation are essential for improving outcomes and addressing the unique needs of Black women facing CML.